ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more
Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more
EUCOPE’s Sounds of Science Podcast – Episode 18 The Revision of the General Pharmaceutical Legislation: European Parliament Reports In this episode of Sounds of Science, we explore the ongoing Revision of the General Pharmaceutical Legislation (GPL). On 10 April, the European Parliament adopted their reports… read more
On 10 April 2024, the European Parliament adopted the two reports on the Revision of the EU General Pharmaceutical Legislation, namely the Directive on medicinal products for human use and the Regulation on authorisation and supervision of medicinal products for human use and governing rules… read more
on ENVI reports on the EU Pharmaceutical Package Today, 19 March 2024, the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) adopted the two reports on the so-called EU Pharmaceutical Package, namely the Directive on Medicinal products for human use and… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
On 7 September, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs, hosted the third episode of its #LifeScienceLectures webinar series. The focus of the webinar, titled ‘’EU HTA: How will the revised Pharma Package impact the value assessment of therapies?’’ was to shed light on the… read more
On 7 July, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs – hosted the second episode of its Life Science Lectures webinar series. The focus of the webinar, titled ‘’Defining (high) unmet medical need: will it steer innovation towards filling existing gaps?’’, was to dive… read more
EUCOPE, along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, launch the European Coalition for Access to Comprehensive Genomic Profiling (ECGP) The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) along with Exact Sciences, Guardant Health, Illumina, MSD and Novartis, launch the European Coalition for Access… read more
On 30 May, EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs hosted the inaugural episode of its Life Science Lectures webinar series, “Attaching conditionalities to incentives: the right path to improve access?” The episode delved into the incentive system outlined in the EU Pharmaceutical Package,… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
